Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-01 Option Award |
2025-03-04 5:28 pm |
N/A 2035-02-28 |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
109,309 | $0 | 109,309 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 4:55 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
434 | $5.42 | 26,088 (Direct) |
View |
| 2024-03-01 Option Award |
2024-11-27 6:10 pm |
N/A 2034-02-28 |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
90,090 | $0 | 90,090 (Direct) |
View |
| 2024-11-14 Tax Withholding |
2024-11-18 4:30 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
368 | $7.92 | 26,522 (Direct) |
View |
| 2024-08-14 Tax Withholding |
2024-08-16 4:51 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
368 | $7.02 | 26,890 (Direct) |
View |
| 2024-05-14 Tax Withholding |
2024-05-16 7:00 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
368 | $8.36 | 27,258 (Direct) |
View |
| 2024-02-14 Tax Withholding |
2024-02-16 5:12 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
434 | $3.4 | 27,626 (Direct) |
View |
| 2023-11-14 Tax Withholding |
2023-11-16 7:42 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
1,470 | $5.08 | 28,060 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-20 5:21 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
9,500 | $3.63 | 212,649 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-20 5:21 pm |
N/A 2032-06-28 |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
9,500 | $0 | 212,649 (Direct) |
View |
| 2022-11-14 Option Award |
2022-11-16 7:13 pm |
N/A 2032-11-13 |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
80,120 | $0 | 80,120 (Direct) |
View |
Ownership |
2022-11-09 8:30 pm |
N/A 2032-06-28 |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
0 | $0 | 192,619 (Direct) |
View |